Bispecific Antibodies: Bridging Targets and Effector Molecules

Bispecific Antibodies: Bridging Targets and Effector Molecules Overview

Bispecific Antibodies - Bridging Targets and Effector Molecules

Bispecific antibodies are a class of engineered antibodies designed to bind simultaneously to two antigens or epitopes. They serve as a crucial bridge between target cells and effector molecules or cells, enabling specific cytotoxicity of the effector cells. This mechanism plays a pivotal role in reducing the likelihood of immune escape.

Leveraging our extensive expertise in antibody development and building upon the established CLC mouse model, our company offers rapid and efficient bispecific antibody development services to our valued customers. Our one-stop service platform covers a comprehensive range of activities, including antibody sequence screening, assembly, and expression of bispecific antibodies, culminating in rigorous antibody quality control analysis.

All Antibody Discovery Services

Utilizing advanced biotechnology, our engineered bispecific antibodies bind two distinct targets. This innovation has the potential to revolutionize therapeutic strategies, heightening specificity, expanding treatment options, and paving the way for future medical advancements.

Using antibodies with high specificity, we guarantee precise binding targets for CAR-T cells and biologics. This meticulous approach is foundational to therapeutic success and patient outcomes. Promoting next-generation healthcare solutions.
ai drug discovery service
Nanobodies, known for their small molecular weight, high affinity, stability, permeability, and cost-effectiveness, have demonstrated tremendous potential in disease …